Pathogenic T cells in individuals with rheumatoid arthritis (RA) infiltrate non-lymphoid tissue sites, maneuver through extracellular matrix and form lasting inflammatory microstructures. Here we found that RA T cells abundantly express the podosome scaffolding protein TKS5, which enables them to form tissue-invasive membrane structures. TKS5 overexpression was regulated by the intracellular metabolic environment of RA T cells-specifically, by reduced glycolytic flux that led to deficiencies in ATP and pyruvate. ATP lo pyruvate lo conditions triggered fatty acid biosynthesis and the formation of cytoplasmic lipid droplets. Restoration of pyruvate production or inhibition of fatty acid synthesis corrected the tissue-invasiveness of RA T cells in vivo and reversed their proarthritogenic behavior. Thus, metabolic control of T cell locomotion provides new opportunities to interfere with T cell invasion into specific tissue sites.
The autoimmune syndrome RA causes relentless joint inflammation that eventually damages cartilage and bone 1 . T cells are key pathogenic drivers that sustain synoviocyte proliferation, tissue inflammation, neoangiogenesis, bony erosion and autoantibody formation 2, 3 . RA T cells age at a faster rate compared with T cells of healthy individuals, acquiring aged phenotypes 20 years prematurely 4, 5 . Functionally, they are prone to differentiation into proinflammatory effector cells that produce excess inflammatory cytokines and amplify the inflammatory activity of non-T cells in the synovial tissue 6, 7 .
The bias of RA T cells toward commitment to proinflammatory effector functions is mechanistically linked to defective metabolic regulation [8] [9] [10] . Specifically, these cells do not sufficiently upregulate the glycolytic enzyme PFKFB3, which curbs lactate and ATP generation 11 . Instead, they shunt glucose into the pentose-phosphate pathway (PPP), hyperproduce NADPH, and accumulate reduced glutathi one 8, 9, 11 , thereby causing insufficient activation of the redox-sensing kinase ATM, a cell-cycle regulator and DNA-repair molecule 9, 12 . RA T cells with low amounts of ATM and reactive oxygen species (ROS) bypass the G2/M cell-cycle checkpoint, hyperproliferate and accelerate naive-to-memory T cell conversion. ATM deficiency causes RA T cells to deviate toward differentiation into type 1 helper T cells (T H 1 cells) and IL-17-producing helper T cells (T H 17 cells), a phenotype corrected by ROS replenishment 9 .
The PPP enables cells to build chemical constituents for the synthesis of macromolecules such as DNA, RNA, proteins and membranes 13 -a critical prerequisite for biomass generation during massive T cell expansion 14 . The PPP product NADPH functions as a reducing agent for anabolic reactions, such as lipid and cholesterol biosynthesis [15] [16] [17] . Glucose delivers carbon for various lipid classes, but most of the de novo synthesized fatty acids (FAs) are incorporated into phospholipids for membrane biogenesis 18, 19 and localize to lipid rafts to participate in crucial membrane-based processes 20 . The rate-limiting step of FA biosynthesis generates malonyl-CoA from acetyl-CoA by acetyl-CoA carboxylase 1 (encoded by ACACA) 21 . Subsequent synthetic steps and FA elongation require fatty acid synthase (FASN), stearoyl-CoA desaturase (SCD), and the fatty acid-coenzyme A ligase family to generate diacetylglycerols, triacetylglycerols and long-chain FAs 16 . Through mitochondrial β-oxidation, FA catabolism feeds NADH and FADH 2 into the electron-transport chain and generates acetyl-CoA to fuel the citric acid cycle 17, 22 . T cells depend on glucose, amino acids and lipids as energy sources, but their metabolic preferences are tightly linked to particular life cycle stages 17, 23, 24 .
Pathogenic T cell functions in RA include trafficking to the joint, diapedesis into the matrix, transit within tissue and the construction of compact microarchitectures 25 . T cell diapedesis from blood vessels involves the formation of 'invasive podosomes' to build transcellular pores 26 . Once in the matrix, T cells resort to nonproteolytic migration, maneuvering through extracellular space with an amoeba-like movement, adaptively changing shape to crawl along collagen fibrils and squeezing through pre-existing matrix gaps 27 . Such T cell mobility requires the dynamic formation of cell protrusions, which are regulated by the cellular cytoskeleton to accomplish cellular spreading, polarization and ultimately cell motion. Small Rho family GTPases activate actin filament assembly factors to form sheet-like lamellipodia and ruffles, and finger-like filopodia and microvilli 28, 29 . The adaptor molecule TKS5 is critically involved in determining the localization of membrane protrusions 30 . Clustering of TKS5 at the plasma membrane facilitates F-actin assembly and enhances the interaction of multiple proteins assembled in podosomes, including the nucleation promoting factor N-WASP 30 , the SH3/SH2 adaptor Grb2 (ref. 30) , ADAM-family metalloproteases, and the adhesion receptor dystroglycan 31 .
1 0 2 6 VOLUME 18 NUMBER 9 SEPTEMBER 2017 nature immunology A r t i c l e s RA T cells serve as an excellent model system to define the molecular underpinning of pathogenic T cell behavior. Previous studies have defined a state of metabolic reprogramming in RA T cells: as PFKFB3 lo G6PD hi cells, they divert glucose away from energy production toward biosynthetic fitness 8, 9, 11 . Here we show that the rewiring of cellular metabolism renders RA T cells tissue invasive, directly promoting disease-inducing effector functions. The ATP lo pyruvate lo NADPH hi metabolic state induced an energystorage mode with excess synthesis of FAs and cytoplasmic lipid droplet (LD) deposition. This resulted in an upregulated T cell locomotion program, high production of the podosome scaffolding protein TKS5, and ultimately a functional phenotype of hypermotility. TKS5 hi RA T cells spontaneously formed actin-and cortactin-rich membrane ruffles, which empowered them to penetrate into nonlymphoid tissue and establish lasting inflammatory infiltrates. Two metabolic interferences corrected the tissue-invasiveness of RA T cells: enhanced activity of pyruvate kinase, and disruption of the downstream effect of excessive lipid storage by FA-synthase targeting. Both interventions amended TKS5 overproduction, prevented T cell entry into synovial tissue and provided effective protection from tissue inflammation in vivo.
RESULTS

RA T cells upregulate the locomotion program
A key pathogenic property of RA T cells is their ability to rapidly invade the synovial membrane, maneuver through extravascular space and polarize into proinflammatory effector cells 11, 32 . The tissue infrastructure and chemokine milieu contribute to the attraction and retention of T cells 32, 33 . We explored whether RA T cells have intrinsic defects that increase their tissue-invasiveness.
To understand the T cell locomotion program, we first probed the migratory capacity of RA and healthy human activated naive CD4 + T cells in a chemokine-free system. Almost twice as many RA CD4 + T cells as healthy control cells migrated through porous membranes, even in the absence of a chemotactic gradient (Fig. 1a) . To identify potential factors influencing CD4 + T cell motility, we examined the cells' amoeba-like motion through extracellular matrix in a 3D collagen gel system that was also chemokine free. We loaded stimulated CD4 + T cells onto the gel surface, marked matrix-infiltrating cells with the nuclear stain DAPI, and quantified the invasion depth by optical sectioning every 100 µm (Fig. 1b-d) . Compared with healthy cells, RA CD4 + T cells entered the collagenous matrix in higher numbers and moved farther within the matrix (700 µm, compared with 500 µm for healthy cells (Fig. 1b-d)) .
After an early period of random walk, T cells form organized membrane extensions for directed motion 32 . We thus analyzed cell shape and membrane protrusions in proliferating RA and control CD4 + T cells (Fig. 1e,f) . Given cortactin's involvement in the formation of lamellipodia and invadopodia 29, 34 , we quantified the expression of this core element of the locomotion program. Protein expression of cortactin and of the cytoskeletal protein F-actin was more than doubled in patient-derived cells (Fig. 1f) . Healthy CD4 + T cells had a thin peripheral actin cortex, whereas F-actin and cortactin clustered in broad-based membrane ruffles in RA T cells (Fig. 1e) . Merged F-actin-cortactin expression was sevenfold higher in patient-derived cells compared with control cells (Fig. 1f) .
We subsequently compared healthy and RA CD4 + T cells for the expression of a core group of genes associated with the cell's locomotion machinery. We stimulated T cells and then analyzed gene expression by RT-PCR after 72 h. In a cohort of six patient-control pairs, ten motility-related genes had consistently higher expression in patient-derived T cells compared with cells from healthy controls (Fig. 1g) . Specifically, RA T cells expressed higher transcript levels of SH3PXD2A, which encodes the TKS5 adaptor protein 35 , a molecule that facilitates the formation and stabilization of cellular projections. Flow cytometry confirmed overexpression of TKS5 (Fig. 1h,i) .
To examine the pathogenic relevance of aberrant TKS5 expression in patient-derived T cells, we investigated the cells' propensity for tissue invasion in a chimeric mouse model. We implanted human synovium into NSG mice and subjected the chimeras to adoptive transfer of human T cells 9, 33, 36 . We tracked synovium-invasive T cells by immunohistochemistry and gene expression profiling of the explanted tissue grafts (Fig. 1j-l) . Few healthy T cells infiltrated the synovial tissue (Fig. 1j-l) . Transfer of RA peripheral blood mononuclear cells (PBMCs) produced a dense T cell infiltrate. Knockdown of SH3PXD2A (Supplementary Fig. 1 ) before adoptive transfer disrupted the invasive capabilities of RA T cells (Fig. 1m-o) . Conversely, TKS5 overexpression (Supplementary Fig. 1 ) in healthy T cells resulted in enhanced T cell invasion, such that TKS5 hi control T cells mimicked patient-derived T cells (Fig. 1p-r) . We then tested whether TKS5 expression in activated CD4 + CD45RA + T cells collected from subjects with RA correlated with the clinical activity of their joint disease. Subjects with higher disease activity, as measured through clinical disease-activity indices, transcribed progressively higher levels of SH3PXD2A mRNA in their T cells compared with those in healthy controls ( Fig. 1s ; R = 0.63).
Thus, RA T cells were equipped to dynamically form membrane ruffles, spread and move, and with spontaneous upregulation of their locomotion gene module they rapidly invaded non-lymphoid tissue sites. The scaffolding protein TKS5 seemed to be nonredundant for this invasive behavior.
TKS5 expression is metabolically regulated
A key characteristic of RA T cells is their metabolic reprogramming. Specifically, RA T cells shunt glucose away from glycolysis toward the PPP, and thus produce less ATP but more NADPH than their healthy counterparts 9, 11, 17 . We therefore explored whether the T cell locomotion module is under metabolic control. We mimicked the slowed glycolytic breakdown in RA T cells by treating healthy CD4 + T cells with the PFKFB3 inhibitor 3PO (200 nM, 72 h). Conversely, we treated patient-derived T cells with the FA synthase (FAS) inhibitor C75 (20 µM, 72 h) to inhibit increased NADPH-dependent FA synthesis. We chose the concentrations of the inhibitors on the basis of dose-response experiments (Supplementary Fig. 2) . Expression of the TKS5-encoding gene SH3PXD2A was highly sensitive to metabolic interference. PFKFB3 blockade increased SH3PXD2A transcript levels, whereas FAS inhibition decreased them (Fig. 2a,b) . Expression of five additional genes from the locomotion module normalized in C75-treated RA T cells. PFKFB3 inhibition effectively increased motility gene expression by >40% for eight of the nine genes tested (Fig. 2c) . We used flow cytometric analysis to assess TKS5 protein expression. PFKFB3 inhibition increased TKS5 expression, thus mimicking the phenotype of RA T cells (Fig. 2d,e,h-j) . Reduced FA synthesis had the opposite effect, correcting the TKS5 overexpression in RA T cells and restoring a normal phenotype (Fig. 2f,g,k-m) . These data directly implicated glycolytic activity and FA synthesis as regulatory steps in locomotion function, thus suggesting a broader effect of metabolic control on normal and pathogenic T cell effector functions. BODIPY staining showed accumulation of cytoplasmic neutral lipids in RA T cells, with BODIPY intensity eightfold higher in RA T cells than in control and PsA T cells (Fig. 3a,b) . Naive as well as memory CD4 + T cells from RA subjects accumulated cytoplasmic LDs (Fig. 3c) . To test whether LD formation occurs in individuals with RA in vivo, we stained tissue sections from RA synovial biopsies. Synovial T cells resembled ex vivo-stimulated T cells, harboring densely packed lipid bodies in their cytoplasm (Fig. 3d) . As an additional readout of lipid biosynthesis, we quantified palmitic acid (C-16) in stimulated T cells from healthy individuals and from subjects with either RA or PsA. Significantly elevated concentrations of palmitic acid were a distinguishing characteristic of RA T cells (Fig. 3e) . Finally, we analyzed the gene module relevant for the process of droplet formation, including BSCL2, PLIN1 and CIDEC (FSP27). Expression for all three genes was selectively higher in RA T cells compared with that in healthy and PsA T cells (Fig. 3f) . Thus, RA T cells, including tissue-inflammatory T cells, were committed to an anabolic lipid-biosynthesis program, which led to cytoplasmic storage of excess FAs. The shift toward anabolic metabolism occurred in the setting of reduced glycolytic activity and overall energy starvation.
To better understand the process of LD accumulation, we analyzed the expression of genes encoding key lipid biosynthesis molecules in a discovery cohort of ten subjects with RA and age-matched controls. We stimulated purified CD4 + CD45RA + T cells with anti-CD3/CD28-coated beads for 72 h. RT-PCR analysis showed markedly higher expression of 20 lipogenesis genes in patient-derived T cells compared with that in controls (Fig. 4a) , which we confirmed in a validation cohort of six RA subjects and six matched controls (Fig. 4b) . Most significant changes were seen in genes encoding enzymes that facilitate de novo FA synthesis (ACACA, FASN and SCD) or esterification (ACSL3/4/5/6 and DGAT1/2) (Fig. 4b) . Three of five genes relevant for mitochondrial β-oxidation (HADHA, HADHB and ACADM) were expressed at significantly higher levels in RA T cells compared with controls (Fig. 4b) .
Kinetic studies showed no differences in ACACA, FASN and SCD transcripts in resting cells but higher induction in RA T cells compared with that in control cells 2-6 d after activation (Fig. 4c) . Immunoblotting confirmed markedly higher expression of the corres ponding proteins in RA T cells compared with controls (Fig. 4d) .
Not all genes related to intracellular lipid homeostasis were affected by the shunting toward lipid anabolism in RA T cells. CPT1 regulates the carnitine-dependent cytoplasm-to-mitochondria transport of long-chain fatty acyl-CoAs. Expression levels of CPT1A and CPT1B were indistinguishable between control and RA T cells (Fig. 4e) . Also, genes involved in cholesterol biosynthesis, previously reported to be critical in the early expansion of CD8 + effector T cells 37 , were not part of the metabolic signature distinguishing RA T cells from those of healthy controls (Fig. 4f) . The lipid storage in RA T cells was highly sensitive to inhibition of FAS with 20 µM C75, which cleared cytoplasmic LDs (Fig. 4g-j) , placing this enzyme at the pinnacle of the altered lipid-biosynthesis program. In summary, after activation, RA T cells induced a broad, yet selective, lipogenic gene program focused on FA and LD formation, but sparing cholesterol production.
Relationship of lipid droplet formation to glycolytic activity Next we aimed to connect the processes of glycolysis, LD formation and T cell locomotion. Quantification of core metabolites at the interface of glycolysis and FA synthesis demonstrated that RA T cells were low in pyruvate and ATP, but had elevated levels of acetyl-CoA (Fig. 5a) . To mimic these conditions and generate an ATP lo pyruvate lo state, we slowed glycolytic flux in healthy CD4 + T cells by treating them with the PFKFB3 inhibitor 3PO (200 nM) or the pyruvate kinase isozyme type M2 (PKM2) inhibitor shikonin (250 nM) (Fig. 5b-e and Supplementary  Figs. 2 and 3) . This metabolic intervention promptly induced LD formation in healthy T cells (Fig. 5b-e) , mimicking the RA phenotype. We also activated lipid-synthesizing RA T cells in the presence of ML265 (10 µM), which forces pyruvate kinase into a high-activity tetrameric formation 38, 39 , or we treated the RA T cells with supplemental pyruvate (1 µM) (Supplementary Fig. 3 ). Pyruvate replenishment from extracellular or intracellular sources significantly reduced the LD load ( Fig. 5f-i) . Enhanced glycolytic flux through ML265 or exogenous pyruvate reduced transcript concentrations for FASN, which encodes a key enzyme in FA synthesis (Fig. 5j) , mechanistically connecting pyruvate availability to the lipogenic machinery. We considered whether the bias toward lipogenesis in RA T cells might be related to activators of peroxisome proliferatoractivated receptor (PPAR) signaling, although treatment of human T cells with well-established PPAR-α or PPAR-γ activators has been reported to induce a potent anti-inflammatory program, with effective suppression of proinflammatory cytokines 40 . PPAR-γ protein expression was similar in control and LD-containing RA T cells, and expression levels were independent of enhanced or reduced glycolytic flux ( Supplementary  Fig. 4) , which suggests that it is unlikely that PPAR-γ signaling is involved in shifting the metabolic homeostasis of RA T cells.
These results delineated a direct effect of glycolysis on lipid anabolism and indicated that pyruvate and ATP deficiency promoted de novo FA synthesis and cytoplasmic deposition.
PFKFB3 silencing induces tissue invasiveness
To test whether the pinnacle defect in T cell hypermotility arises from insufficient glycolytic breakdown, we determined whether pharmacologic and genetic PFKFB3 impairment is sufficient to impose the RA phenotype on healthy T cells. We assigned synovium-engrafted NSG mice to one of four treatment arms: reconstitution with healthy CD4 + T cells transfected with control or PFKFB3-specific siRNA, or treated with or without 3PO (200 nM). We quantified synovitis intensity by enumerating synovial CD3 + T cells and by analyzing the gene expression of ten key inflammatory mediators. PFKFB3 knockdown reduced amounts of PFKFB3-specific transcripts by 50% ( Supplementary  Fig. 5 ), thereby mimicking RA T cells 9, 11 . The reduction of PFKFB3 transcript levels was durable over >96 h (Supplementary Fig. 5 ), which allowed us to carry out in vivo testing of functional consequences. Suppression of PFKFB3 function promoted aggressive T cell infiltration followed by strong innate and adaptive inflammation (Fig. 6) , including expression of TNFSF11, thus suggesting the recruitment and retention of RANKL + T cells and tissue production of TNF, IL-6 and IL-1β (Fig. 6f) . Quantification of IFN-γ-producing effector T cells in the tissue lesions (Fig. 6d,e,j,k) showed that reduced PFKFB3 function resulted in a two-to threefold increase in the frequency of synovial T cells producing this effector cytokine.
Together, these data indicated a critical role for pyruvate generation in controlling T cells' bioenergetics, tissue-invasiveness and proinflammatory potential.
Metabolic interference corrects T cell tissue-invasiveness
To investigate whether the locomotion program of RA T cells is amenable to metabolic interference in vivo, we used the human synovium-NSG model system. We transferred RA-patient-derived T cells into NSG mice engrafted with human synovial tissue 9, 33, 36 . The RA T cells demonstrated high tissue invasion, which resulted in robust synovitis with tissue expression of TNFSF11 (encoding RANKL), TNF, IL-6 and IL-1β (Fig. 7) . Tissue-resident T cells were characterized by expression of RANKL, strong IFN-γ and IL-17 upregulation (Fig. 7c,d,f,g ), and dominance of the lineage-determining transcription factors 
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T-bet and RORγt (Fig. 7e) . Lipogenesis retardation by inhibition of FA synthesis with C75 (5 mg/kg body weight per mouse) efficiently suppressed tissue inflammation (Fig. 7) , reduced the infiltration of RANKL + T cells (Fig. 7a,b) , diminished the overall density of the T cell infiltrate (Fig. 7c) and resulted in the depletion of IFN-γ + T cell populations (Fig. 7f,g) . Expression of Foxp3, a marker of anti-inflammatory regulatory T (T reg ) cells, was unaffected (Fig. 7e) . Chimeras tolerated C75 treatment, with no obvious toxic effects on transferred human cells (Supplementary Fig. 6 ). We then restored pyruvate synthesis with the PKM2 activator ML265 (10 mg/kg per mouse), which corrected the metabolic disbalance in RA T cells (Fig. 5) . Increased pyruvate availability resulted in striking beneficial effects in vivo (Fig. 7) . pyruvate kinase activation attenuated T cell accumulation, reduced the production of TNF and RANKL, and minimized amounts of T cell cytokines (IFN-γ and IL-17). In contrast to blocking of FA synthesis, ML265 treatment left IL6 and IL1B gene expression unaffected (Fig. 7e) . ML265 was also less potent than C75 in preventing IFN-γ + T cell infiltration, although it was still highly effective (Fig. 7f,g) .
These experiments demonstrated the reversibility of abnormal T cell locomotion and placed defective glycolysis upstream of the tissue-invasiveness of RA-patient-derived T cells.
DISCUSSION
T cell pathogenicity depends on several functional domains, including trafficking to peripheral tissues and maneuvering in the tissue environment. Here we define glycolytic flux and FA biosynthesis as critical checkpoints in the inflammatory activity of T cells that ultimately determine membrane configuration and tissue invasiveness. T cells from individuals with RA reshape their membranes and are hypermotile and tissue-penetrating, which enables their proinflammatory effector properties in the joint. The energy-consuming process of tissue invasion by RA T cells is linked to an ATP lo pyruvate lo state, and pyruvate replenishment is sufficient to abrogate the cellular motility, tissue infiltration and inflammatory potential of these cells.
The pinnacle defect appears to be malfunctioning glycolytic flux and shunting of glucose to the PPP, which diverts energy use to a synthetic pattern. Accordingly, impaired glycolytic breakdown in healthy T cells suffices to convert them into tissue-invasive and arthritogenic effectors. Shifting the balance between catabolic and anabolic glucose utilization might be an effective strategy to set the threshold for T-cell-dependent tissue inflammation.
To minimize heterogeneity within T cell populations, we focused on naive CD4 + CD45RA + T cells, which exemplify massive biomass generation demands after activation, combined with the need for invasive capabilities to reach relevant tissue sites. RA T cells are distinguished from their healthy counterparts by dampened glycolytic breakdown, reduced pyruvate production, and accelerated PPP shunting 8, 9, 11 . Instead of adopting a primarily catabolic program, they utilize anabolic biosynthesis. FA overproduction leads to cytoplasmic LD deposition commensurate with biosynthetic prerequisites for massive growth, cell cycle passage 23 and accelerated naive-to-memory T cell conversion 17, 24, 41 . The price is the exhaustion of the naive T cell compartment and the accumulation of enddifferentiated effector memory T cells. After bypassing the G2/M A r t i c l e s cell cycle checkpoint, RA T cells more rapidly commit to IFN-γ and IL-17 production, thus aborting the development of anti-inflammatory T reg cells 9 . An excess amount of NADPH predicts sufficient reductive elements to drive anabolic reactions, specifically lipid-anabolic pathways. Unexpectedly, the bias toward lipid biosynthesis was selective for saponifiable lipids, whereas genetic modules that support cholesterol biosynthesis remained unaffected. Newly activated CD8 + T cells rapidly upregulate lipid biosynthetic pathways, synthesizing both cholesterol and FAs 37 . Sterol regulatory element-binding proteins (SREBPs) control the cholesterol content in such CD8 + T cells 37 , acting within hours of T cell activation and affecting T cell blasting. Interestingly, homeostatic T cell proliferation and T cell pool maintenance seem to be SREBP independent 37 . We propose that cellular cholesterol signals mainly during very early T cell activation, whereas later stages of T cell expansion depend on FAs. Tissue penetration is an absolute requirement for joint-invading T cells. Beyond chemokine-guided trafficking, T cells must form protrusive membrane structures (lamellipodia, ruffles and/or filopodia) to maneuver through the matrix 42 while remaining proteinase independent 27 . Membrane protrusions and amoeba-like crawling ultimately require cytoskeletal support. RA T cells are highly migratory 9 , and low LSP1 expression promotes migration to tissues and lymph nodes, which exacerbates disease severity 43 . Overall, motility relies on actin nucleation in the membrane, such that an actin mesh can propel the cell across a substrate. Accordingly, we examined a core module of motility genes covering key pathways in actin polymerization, cytoskeletal rearrangement and membrane reshaping. Higher expression of the motility gene module corresponded to hypermotility and tissue-invasiveness. Crawling through extracellular space is a membrane-centered process; hence the coupling of high mobility with anabolic metabolism. Cellular ATP content seems to be of less relevance, as the highly motile T cells of subjects with RA were ATP lo . Curbing of the cells' FA content led to prompt downregulation of many of the motility genes. Additional studies could identify the signaling cascades that connect lipid biosynthesis with dynamic cytoskeletal and membrane shaping.
Proliferating naive T cells are glycolysis dependent, whereas effector cells align with distinct metabolic classes 8, 44 . T reg cells emerge under energy-deprived conditions, with low ATP activating AMP-activated protein kinase (AMPK), curtailing mTOR and inhibiting the downstream acetyl-CoA carboxylase. Thus low lipid biosynthesis favors T reg cell differentiation 45 . This paradigm fails in RA T cells, which are pyruvate and ATP deprived 9,11 yet switch to an anabolic program. Pyruvate supplementation and enhanced glycolytic flux efficiently cleared cytoplasmic lipid deposits and corrected the hypermigratory and hyperinflammatory phenotype of RA T cells. Thus, excess lipid storage occurred in the setting of ATP deficiency. Mitochondrial function remained intact in RA T cells, and they generate sufficient citrate to support FA synthesis. However, the AMPK-controlled loop of the coordination of cellular metabolism with functional behavior seems to be defective. Here chronic stimulation and microenvironmental abnormalities may alter the cells' threshold settings and response patterns to metabolic cues. Experiments that reduced PFKFB3 function in healthy T cells demonstrated that glycolytic slowdown is a pinnacle defect in RA T cells. Genetic or pharmacologic PFKFB3 inhibition converted healthy T cells into arthritogenic T cells.
The current data assign metabolic checkpoint functions to intracellular ATP, pyruvate and FAs in controlling disease-relevant properties. By favoring anabolic G6PD over catabolic PFKFB3, RA T cells become primed for cellular growth and differentiation. Excess amounts of FAs convey fitness for immune-surveillance functions, such as migration from secondary lymphoid tissues and invasion of peripheral tissues to establish long-lasting, highly efficient tertiary lymphoid structures 46 IL17 mRNA (a.u.)
ns ns checkpoints and invadopodia formation to seed peripheral tissues with metastases 13 . AMPK regulates invadopodia formation in cancer lines, which reemphasizes the mechanistic link between metabolic homeostasis and tissue invasion 47 3D-collagen invasion assay. CD4 + CD45RA + T cells were stimulated with anti-CD3/CD28-coated beads for 24 h. 5 × 10 4 cells were seeded on top of a 3D collagen matrix (1.5 mg/ml PureCol bovine collagen type I (5005-100ML); Advanced Biomatrix; approximately 5 mm in thickness). Invasion depths were measured after 48 h of culture (37 °C, 5% CO 2 ). The collagen matrix was fixed in 4% (vol/vol) paraformaldehyde and stained with DAPI (1:1,000; D21490; Thermo Fisher Scientific) for 1 h at room temperature. Individual wells filled with the collagen matrix were imaged with an LSM710 microscope with an EC Plan-Neofluar 10×/0.3-NA (numerical aperture) DICI objective lens (Carl Zeiss). Z-stacks were set to begin on the surface of the 3D collagen matrix and reach to the bottom of each well. Five random spots per well were measured, and the difference between the z-position of non-invading, surface-positioned cells and that of the deepest invading cells in the data set was recorded. We prepared optical sections by beginning at 0 µm and cutting progressively at 100-µm intervals. The DAPI signal of each image was quantified after import into ImageJ software. The relative ratios of invading/surface cells were calculated for each measurement.
Analysis of membrane protrusive structures. 5 × 10 4 CD4 + CD45RA + T cells were placed into 96-well plates (Corning) coated with fibronectin (10 µg/ml; 3420-001-01; Trevigen). After 30 min at 37 °C, nonadherent cells were removed and adherent cells were fixed, permeabilized and stained with anti-cortactin (PA5-29799; Thermo Fisher) and rhodamine phalloidin (R415; Thermo Fisher Scientific). Nuclei were visualized with DAPI. The LSM710 system (Carl Zeiss) with a Plan Apochromat 63×/1.40-NA oil DICIII objective lens (Carl Zeiss) was used to acquire images. Podosome-like structures and membrane ruffles were quantified on the basis of F-actin-cortactin colocalization.
Immunohistochemical staining. Cryosections (5 µm) of explanted synovial tissues were stained with H&E and examined for the density and arrangement of inflammatory infiltrates. Synovial T cells were identified by immunohistochemical staining with mouse or rabbit anti-human CD3 (1:50) alone or by costaining with anti-RANKL/CD254 (1:100) or anti-IFN-γ (1:100) as described 9, 36, 48 . Sections were analyzed with an Olympus BX41 microscope and CellSense software. Pyruvate measurements. CD4 + CD45RO − T cells were stimulated with anti-CD3/CD28 beads for 72 h, and pyruvate levels were quantified with pyruvate assay kits (MAK071-1KT; Sigma-Aldrich).
Acetyl-CoA quantification. Acetyl-CoA concentrations were determined with a fluorometric kit (MAK039-1KT; Sigma-Aldrich). CD4 + CD45RO − T cells were stimulated and cultured for 72 h before measurement.
qPCR. RNA extraction and RT-PCR were done as described 39, 48 . Primer sequences are listed in Supplementary Table 2 . Gene expression was normalized to 18S rRNA.
Immunoblotting. Cellular proteins were extracted with cOmplete Lysis-M EDTA-free (04719964001; Sigma-Aldrich). Expression levels were examined after standard western blotting as described 9, 39 .
Plasmids and transfections.
To manipulate SH3PXD2A gene expression, we transfected 20 nM ON-TARGETplus human SH3PXD2A siRNA-SMART pool (9644; GE Healthcare Dharmacon Inc.), control siRNA (Life Technologies), pECE M2-SH3PXD2A WT (69813; Addgene), or control vector into CD4 + CD45RO − T cells that had previously been stimulated with anti-CD3/CD28 beads for 48 h. For silencing of PFKFB3, CD4 + CD45RO − T cells were stimulated with anti-CD3/CD28 beads for 48 h and then transfected with 20 nM ON-TARGETplus PFKFB3 siRNA-SMART pool (5209; GE Healthcare Dharmacon Inc.) or control vector with the Amaxa Nucleofector system and the Human T cell Nucleofector kit (LONZA). Cells were cultured for 24 h under standard conditions before further experiments.
Human synovial tissue-NSG chimeras. NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ (NSG) mice (Jackson Laboratory, Bar Harbor, ME) of both sexes were kept in pathogen-free facilities and used at the age of 10-12 weeks as described 9, 36, 48 . Pieces of human synovial tissue free of inflammatory infiltrates were placed into a subcutaneous pocket. After engraftment, mice were reconstituted with 10 million CD45RO − PBMCs as described 9, 48 . Mice carrying the same synovial tissue and reconstituted with the same population of CD45RO − PBMCs were assigned to parallel treatment arms. The CD45RO − PBMCs were derived from (1) RA patients with highly active disease, (2) age-matched healthy controls, 
